Join

Compare · HUM vs PSNL

HUM vs PSNL

Side-by-side comparison of Humana Inc. (HUM) and Personalis Inc. (PSNL): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both HUM and PSNL operate in Medical Specialities (Health Care), so they compete in similar markets.
  • HUM is the larger of the two at $46.80B, about 25.4x PSNL ($1.84B).
  • Both names hit the wire about 6 times in the past 4 weeks.
  • HUM has more recent analyst coverage (25 ratings vs 15 for PSNL).
MetricHUMPSNL
Company
Humana Inc.
Personalis Inc.
Price
$388.85+0.65%
$17.25+1.02%
Market cap
$46.80B
$1.84B
1M return
-
-
1Y return
-
-
Industry
Medical Specialities
Medical Specialities
Exchange
NYSE
NASDAQ
IPO
2019
News (4w)
6
6
Recent ratings
25
15
HUM

Humana Inc.

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.

PSNL

Personalis Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.